abstract |
The disclosure provides a novel polymorph of Compound (I): n n2-((1-(2-(4-Fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-one monohydrochloride dihydrate, i.e., Form (A) of Compound (I).HCl.2H 2 O. Pharmaceutical compositions comprising Form (A) of Compound (I).HCl.2H 2 O and related methods of treatment are also disclosed. |